Become an Advocate
Use your voice to help secure Federal funding for important diabetes research, inform health and regulatory policy, and improve the quality of life for those affected by T1D until we find cures.
Join Our Community
Now more than ever, we need to stay connected as a community — to support each other and share vital information and resources.
What is #Coverage2Control?
JDRF is calling on insurers, employers, drug companies and the government to provide these three things that will help people with type 1 diabetes (T1D) control the disease.
Lower out-of-pocket costs for insulin and supplies and make costs more predictable.
Give people the freedom to choose the treatment that’s right for them.
Cover all FDA-authorized technology and treatments for T1D.
Impact So Far
We’re making your voice heard where #Coverage2Control decisions are made – at insurance companies, employers, drug manufacturers, and at the U.S. Department of Health & Human Services.
Thousands of messages to insurers
50,000+ people signed the #Coverage2Control petition demanding better coverage for those living with T1D and 12 major groups signed on as partners. JDRF hand-delivered your petitions to the 25 largest health insurance companies, and supporters have sent thousands of personalized follow-up messages.
Artificial pancreas systems covered
All 25 of the nation’s largest health plans now cover artificial pancreas systems, including Anthem, which reversed its policy after hearing from JDRF and the T1D community.
Strongly Oppose Restrictions
After UnitedHealthcare (UHC) announced it was extending its preferred insulin pump agreement to children as young as 7, we met with company leaders to urge them to reconsider this decision. Following that meeting, tens of thousands of letters were sent to UHC by our community as part of this campaign urging this policy be changed. As a result, your voices were heard – on July 1, 2020 UHC revised their policy.
Progress toward lower insulin costs
JDRF has called on drug companies to lower list prices and do more to help the uninsured access affordable insulin. Assistance programs have expanded during the pandemic and JDRF has encouraged these expansions to be made permanent. JDRF continues to be deeply involved in ongoing conversations with Congress and the Administration about this important topic. Read our Congressional Testimony here.
Pressure from the #Coverage2Control campaign has prompted insurers to make improvements. Aetna and Blue Cross Blue Shield of North Carolina are passing drug discounts directly to their members. UnitedHealthcare expanded their drug discount program, announcing that in 2020 all new employer plans would have to pass drug discounts through to the people who need the drugs.
Spread the word
Materials and information to help you educate others.
Learn more about why JDRF is telling insurance companies to provide coverage that works for people with T1D.
See What’s at Stake
See why choice is so important for people with T1D, especially when it comes to choosing an insulin pump.
What JDRF is Fighting For
JDRF plays an important role in accelerating innovation and ensuring access for all Americans with T1D.
Thanks to our partners fighting for #Coverage2Control